Newsletter Subscribe
Join thousands of readers who get our Sunday Briefing: one email, five essential stories, zero fluff. Subscribe NOW!

Think your one-click WordPress accessibility plugin is keeping you compliant? Think again. Most automated tools miss the vast majority of WCAG issues, leaving your site broken for real users and vulnerable to lawsuits.

The Sean Duffy son-in-law controversy is more than just a headline; it's a symptom of a deeper rot in our political system. With $1 million transferred and industry PACs lining up, is this nepotism or shrewd political theater? Let's unpack the allegations, the media frenzy, and the uncomfortable truths about influence and accountability in Washington.

I have spent decades watching Washington, and the current mess is not just business as usual. It is a calculated transformation of how things get done, or more accurately, how things get stopped. Understanding the MAGA caucus requires peeling back the performative layers to see the cold, tactical machinery at work.

Analyzing the intersection of political influence, the volatility of Trump Media stock, and the reality of the 2025 government-seeded Trump Accounts.

Congressional primary elections are the foundation of our legislative system, yet most Americans ignore them. With the 2026 midterm cycle looming, it is time to look at why the system is rigged, who really pulls the strings, and why your vote matters less than you think.

Political media accountability is effectively dead, sacrificed for corporate profits and algorithmic outrage. Discover why trust is at an all-time low and how you can reclaim your own media literacy.

I explore how midterm election strategy relies on voter manipulation and how parties prioritize base mobilization over genuine constituent representation.

Media neutrality is a myth sold to keep you hooked on a specific narrative. Let us look at how bias really shapes your daily news feed.

The 2026 US election exemplifies how performative governance sustains the illusion of democracy. It’s a spectacle driven by money, spectacle, and systemic inertia—leaving real change out of reach.

The Trump administration's promises of cheaper prescription drugs often amounted to little more than political theater, leaving Americans grappling with exorbitant medication costs. From the limited utility of the TrumpRx.gov portal to the complex dance around Medicare drug price negotiation and the empty threats of tariffs, the debate over prescription drug affordability in the US remains mired in performative politics rather than substantive reform. This piece dissects the illusions and exposes the realities behind the policies, questioning the pharmaceutical industry's narratives on R&D and regulatory capture, and urging readers to demand real structural change.